Supernus Pharmaceuticals reported $58.39M in Stock for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Adamas Pharmaceuticals ADMS:US 7.79M 252K
Aerie Pharmaceuticals AERI:US $ 30.7M 2.38M
Ani Pharmaceuticals ANIP:US $ 67.63M 7.71M
Antares Pharma ATRS:US $ 18.64M 0.97M
Aphria Inc APH:CN C$ 340.86M 9.58M
Aurora Cannabis Inc ACB:CN 137.72M 14.81M
Bristol Myers Squibb BMY:US $ 2137M 184M
Canopy Growth Corp WEED:CN C$ 411.67M 43.7M
Corcept Therapeutics CORT:US $ 4.67M 0.28M
Eisai 4523:JP Y 89852M 4734M
Eli Lilly And LLY:US $ 3824.9M 164.1M
Endo International Ordinary Shares ENDP:US $ 338.46M 23.72M
Horizon Pharma HZNP:US $ 258.68M 20.37M
Lannett LCI:US $ 109.54M 3.53M
Pacira Pharmaceuticals PCRX:US $ 65.26M 0.66M
Perrigo Ordinary Shares PRGO:US $ 1115.9M 20.2M
Supernus Pharmaceuticals SUPN:US $ 58.39M 8.16M
United Therapeutics UTHR:US $ 89.9M 2.3M
Xeris Pharmaceuticals Inc XERS:US $ 12.3M 3.95M